MedTrace Logo

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

NCT04425434 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-03-02

No results posted yet for this study

Summary

As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.

Conditions

  • Retinoblastoma

Interventions

OTHER

OBSERVATIONAL

We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.

Sponsors & Collaborators

  • French Africa Pediatric Oncology Group

    lead OTHER

Principal Investigators

  • FOUSSEYNI Mr TRAORE, Dr; · AMCC AND GFAOP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • Burkina Faso
  • Côte d’Ivoire
  • Democratic Republic of the Congo
  • Madagascar
  • Mali
  • Senegal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04425434 on ClinicalTrials.gov